Sellas Shares Surge on Leukemia Vaccine Trial Win
Leukemia vaccine passes key trial, adding to breakthrough year for cancer drugs The Washington Post Vaccine Improves Survival in People with Acute Myeloid Leukemia (AML) Memorial Sloan Kettering Cancer Center Sellas vaccine extends survival in blood cancer trial, shares surge Reuters Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial STAT Sellas marks 9-month survival benefit in late-stage leukemia vaccine study Fierce Biotech